Citation Impact
Citing Papers
Preferential Cytotoxicity of Bortezomib toward Hypoxic Tumor Cells via Overactivation of Endoplasmic Reticulum Stress Pathways
2008
Inhibition of eIF2α Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy
2009
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
Transcriptional Regulation by Nrf2
2017 Standout
The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes
2015
miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer
2012
Unfolded protein response in cancer: the Physician's perspective
2011
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
In-situ immobilization of quantum dots in polysaccharide-based nanogels for integration of optical pH-sensing, tumor cell imaging, and drug delivery
2010
Targeting hypoxia in cancer therapy
2011 Standout
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells
2017
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs
2008
Marine natural products
1990 Standout
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
2012 Standout
Nelfinavir and bortezomib inhibit mTOR activity via ATF4‐mediated sestrin‐2 regulation
2013
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Core–shell hybrid nanogels for integration of optical temperature-sensing, targeted tumor cell imaging, and combined chemo-photothermal treatment
2010
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
The endoplasmic reticulum stress response in aging and age-related diseases
2012
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
An overview of application of silver nanoparticles for biomaterials in dentistry
2018 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Regulation of PERK Signaling and Leukemic Cell Survival by a Novel Cytosolic Isoform of the UPR Regulator GRP78/BiP
2009
Endoplasmic Reticulum Stress and the Hallmarks of Cancer
2016
Regulation of cancer cell metabolism
2011 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma
2010
Oxidative Stress in Cancer
2020 Standout
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
Thermometry at the nanoscale
2012 Standout
Reactive oxygen species in cancer
2010 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
2008 Standout
Targeting autophagy in cancer
2017 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
ROS Are Good
2016 Standout
Cellular mechanisms and physiological consequences of redox-dependent signalling
2014 Standout
Repositioning HIV protease inhibitors as cancer therapeutics
2008
ROS signalling in the biology of cancer
2017 Standout
ER stress-induced cell death mechanisms
2013 Standout
Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity
2015
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Fluorescent silver nanoclusters
2011 Standout
A Novel COX‐2 Inhibitor Pyrazole Derivative Proven Effective as an Anti‐Inflammatory and Analgesic Drug
2010
Hypoxia signalling through mTOR and the unfolded protein response in cancer
2008
Targeting ER stress induced apoptosis and inflammation in cancer
2010
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Luminescent probes and sensors for temperature
2013 Standout
The integrated stress response
2016 Standout
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
2015
Fundamentals of cancer metabolism
2016 Standout
Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironmentviamyeloid-derived suppressor cells
2014
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Proteomic Analysis of Anti-Tumor Effects of 11-Dehydrosinulariolide on CAL-27 Cells
2011
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
The role of declining adaptive homeostasis in ageing
2017
Cellular Stress Responses: Cell Survival and Cell Death
2010
NSAIDs Inhibit Tumorigenesis, but How?
2013
Assessment of celecoxib pharmacodynamics in pancreatic cancer
2006
mTOR signaling at a glance
2009 Standout
Works of Peter Pyrko being referenced
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
2006
Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib
2007
Celecoxib transiently inhibits cellular protein synthesis
2007
Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-Celecoxib
2008
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib
2007
The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant Gliomas
2007
HIV-1 Protease Inhibitors Nelfinavir and Atazanavir Induce Malignant Glioma Death by Triggering Endoplasmic Reticulum Stress
2007